ASO targeting of this mutation successfully restored mRNA splicing, CEP290 expression and cilia in patient cells and patient iPSC-derived retinal organoids (Gerard et al., 2012; Parfitt et al., 2016) and led to vision improvement in LCA patients (Cideciyan et al., 2019). This evidence concerns the gene CEP290 and Leber congenital amaurosis.